Skip to main content
. 2020 May 15;17(2):501–512. doi: 10.20892/j.issn.2095-3941.2019.0397

Figure 2.

Figure 2

Maximum and whole-course changes in sizes of target lesions vs. baseline after apatinib treatment of stage IV osteogenic sarcoma that did not respond to chemotherapy. (A) Maximum changes in sizes of target lesions vs. baseline after apatinib treatment of stage IV osteogenic sarcoma that did not respond to chemotherapy. (B) Whole-course changes in sizes of target lesions vs. baseline after apatinib treatment for stage IV osteogenic sarcoma that did not respond to chemotherapy.